Wei Lin
Revolution Medicines, Inc. Warrant · Chief Medical Officer
Wei Lin is listed in filings as Chief Medical Officer at Revolution Medicines, Inc. Warrant. This profile follows SEC Form 4 activity through Mar 19, 2026, including sale activity. Recent filings connect the profile to Revolution Medicines, Inc. Warrant (RVMDW), Revolution Medicines, Inc. (RVMD), and 2seventy bio, Inc. (TSVT). The current snapshot covers public activity from Jun 12, 2024 to Mar 19, 2026. Reported amounts are shown as $206.2K to $99.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $206k2.1k shares | SellMar 17, 2026 | $99.48 | $6.90 | |
| $206k2.1k shares | SellMar 17, 2026 | $99.48 | $153.00 |